ask="5.22"
ask_size="5000"
average_daily_volume="504295"
bid="4.24"
bid_size="1700"
book_value="3.74"
change="-0.08"
change_from_200_day_moving_average="2.61"
change_from_50_day_moving_average="0.12"
change_from_52_week_high="-6.73"
change_From_52_week_low="0.32"
change_in_percent="-1.72%"
close="4.56"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.37"
ebitda="-41.42M"
eps_estimate_current_year="5.02"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.03"
ex_dividend_date="N/A"
float_shares="13385000"
high="4.74"
high_52_weeks="11.29"
last_trade_date="1/12/2017"
last_trade_price="4.56"
last_trade_size="195"
last_trade_time="3:59pm"
low="4.50"
low_52_weeks="4.24"
market_capitalization="102.83M"
moving_average_200_day="1.95"
moving_average_50_day="4.44"
name="Cascadian Therapeutics
Inc."
notes="N/A"
one_year_target_price="390.00"
open="4.60"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+133.92%"
percent_change_from_50_day_moving_average="+2.68%"
percent_change_from_52_week_high="-59.63%"
percent_change_from_52_week_low="+7.63%"
previous_close="4.64"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.24"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="22551000"
short_ratio="5.06"
stock_exchange="NMS"
symbol="CASC"
volume="44471"
weeks_range_52="4.24 - 11.29"
